Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema.

Maria L Lara-MarquezSandra C ChristiansenMarc A RiedlJack HerschbachBruce L Zuraw

Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2018)

The stimulated kallikrein activity assay allows differentiation of bradykinin- from histamine-mediated angioedema. The assay could feasibly be considered as a potential clinical tool for the diagnosis of bradykinin-mediated angioedema.

Keyphrases

angiotensin converting enzyme
high throughput
risk assessment
climate change
human health